Two UNC researchers design a biological test to individualize chemotherapy.
UNC Lineberger Comprehensive Cancer Center member Jared Weiss, MD is teaming up with the cancer advocacy organization Global Resource for Advancing Cancer Education (GRACE) to offer a free webinar
UNC Lineberger members make major contribution to President’s Cancer Panel report on HPV vaccination
Members of the University of North Carolina Lineberger Comprehensive Cancer Center played a major role in developing the recommendations in a President’s Cancer Panel (PCP) report urging a widespread public campaign to increase the rate of human papillomavirus (HPV) vaccination.
The work of UNC School of Medicine Professor and Lineberger member John Baron, MD, is featured in an article titled "Can aspiring fight cancer?" The article provides an overview of recent studies that suggest regular doses of aspirin can help prevent some types of cancer.
The oncogene RAS is linked to 30 percent of human cancers, but the search for a targeted therapy for RAS has remained elusive. Three leading RAS researchers from the University of North Carolina Lineberger Comprehensive Cancer Center are playing leading roles at a conference aimed at discussing recent advances that may lead to new advances in targeting the oncogene.
Clinical trials that show positive patient response to systemic therapies for cancer should not necessarily lead to reduction in the use of local therapies such as radiation and surgery.
The Lung Cancer Initiative of North Carolina (LCINC), the state’s leading non-profit organization supporting lung cancer research and education, is proud to welcome Dr. Jared Weiss, medical oncologist with UNC Lineberger Comprehensive Cancer Center’s Thoracic Oncology Program, to serve on the board of directors.
UNC Lineberger member Russell Harris, MD, MPH, Professor of Medicine in the UNC School of Medicine and Adjunct Professor of Epidemiology in the UNC Gillings Global School of Public Health, was quoted in two articles in the New York Times about a major study of the efficacy of breast cancer screening published by BMJ (formerly British Medical Journal).
A comprehensive genetic analysis of invasive bladder cancer tumors has found that the disease shares genetic similarities with two forms of breast cancer, according to researchers at the University of North Carolina Lineberger Cancer Center. Bladder cancer, which is the fourth most common malignancy in men and ninth most common in women in the United States, claimed more than 15,000 patients last year.
“This is an important finding because of the field’s increased interest in ‘metabolic reprogramming’ of immune cells. Understanding how macrophage substrate metabolism impacts inflammation is crucial to our being able to develop novel therapies for obesity and diabetes, and even cancer," said study author Liza Makowski, PhD, assistant professor of nutrition at the Gillings School and member of the UNC Lineberger Comprehensive Cancer Center.
UNC Lineberger receives jointly awarded $1 million research grant to investigate novel target in melanoma
The $1 million award from the Melanoma Research Alliance and the Saban Family Foundation will support research to improve the treatment of melanoma, the most aggressive type of skin cancer.
A team led by Cyrus Vaziri, PhD, and William Janzen at the University of North Carolina at Chapel Hill has received a grant from the National Institutes of Health for research that could help make chemotherapy drugs more effective.
The response of a patient with metastatic brain tumors to treatment with stereotactic radiosurgery in the first six-to-twelve weeks can indicate whether follow-up treatments and monitoring are necessary, according to research conducted at the University of North Carolina.
The UNC Lineberger Comprehensive Cancer Center announces The Marci Kramish Campbell Dissertation Award, a competitive $5,000 award to recognize excellence in dissertation research focused on cancer and the population sciences. This cash award goes directly to the recipient and can be used for any purpose.
The journal highlights research performed by UNC Lineberger member Angela Smith, MD, that links a loss of muscle mass, known as sarcopenia, in women to complications from a cystectomy. Women who experienced sarcopenia were found to have a 43 percent chance of major complications compared to 10 percent for women who did not experience muscle loss.
While ultrasound provides a less expensive and radiation-free alternative to detecting and monitoring cancer compared to technologies such as X-rays, CT scans and MRIs, the lower clarity and resolution of ultrasound has limited its use in cancer treatment. Researchers at the University of North Carolina at Chapel Hill have overcome this limitation by combining ultrasound with a contrast agent comprised of micro-sized bubbles that pair with an antibody produced at elevated levels by many cancers.
Qi Zhang sees himself as a warrior. In his lab at the University of North Carolina at Chapel Hill, he wages war on genetic diseases such as cancer and heart disease on a battlefield measured with single atoms.
The Oncology Nursing Society Foundation selected MSN student Sean Gallagher, RN, for a 2013 APN/DNP Student Fellowship. Mr. Gallagher's fellowship will cover the costs of his research project "Survivors of HPV-Related Oropharyngeal Cancer--Knowledge of Human Papillomavirus (HPV) and Impact of HPV on Sexual Intimacy."
The annual compilation of The Best Doctors in America® includes 53 physicians affiliated with the University of North Carolina’s Lineberger Comprehensive Cancer Center.
Sha Chang, Otto Zhou, and collaborators have built the first small device that can produce these kind of microbeams, opening up a new area of research for cancer scientists.
Dr. Lisa Carey, MD, medical director of the UNC Breast Center and associate director for clinical science at UNC Lineberger Comprehensive Cancer Center, is one of the experts interviewed by MedPage Today on recent advances in cancer research.
The next chapter in the story of UNC Lineberger Comprehensive Cancer Center begins with a new director, Ned Sharpless, an oncologist with a story to tell.
The cost of insurance co-payments for cutting-edge pharmaceuticals can vary widely from patient to patient. When the patient’s share of prescription costs becomes too high, many patients skip doses or stop taking medication entirely, according to research conducted at the University of North Carolina.
The Charlotte Observer - Mersereau comments on fertility preservation for young adults battling cancer
Dr. Jennifer Mersereau, a fertility preservation specialist at UNC Cancer Care, comments on the promise and challenge of fertility preservation for individuals battling cancer.